The NKG2D ligand ULBP4 binds to TCRγ9/δ2 and induces cytotoxicity to tumor cells through both TCRγδ and NKG2D

Blood

Volumn 114, Issue 2, 2009, Pages 310-317

  Kong, Yan ^a   Cao, Wei ^a   Xi, Xueyan ^a   Ma, Chi ^a   Cui, Lianxian ^a   He, Wei ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN ULBP4; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR DELTA 2; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA 9; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; CYTOKINE; HLA ANTIGEN CLASS 1; KLRK1 PROTEIN, HUMAN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; RAET1E PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSURVEILLANCE; IN VITRO STUDY; LEUKEMIA CELL LINE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH1 CELL; TUMOR CELL; VIRUS INFECTION; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; MOUSE; T LYMPHOCYTE; THYMOMA;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; THYMOMA;

EID: 67651087317     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-12-196287     Document Type: Article

References (42)

1. Hayday AC. γδ cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol. 2000;18:975-1026.
2. Triebel F, Hercend T. Subpopulations of human peripheral T gamma delta lymphocytes. Immunol Today. 1989;10:186-188. (Pubitemid 19133697)
3. Wu J, Groh V, Spies T. T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC classI-related chains by human epithelial T cells. J Immunol. 2002;169: 1236-1240. (Pubitemid 34809164)
4. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced molecules by intestinal epithelium γδ T cells. Science. 1998;279:1737-1740. (Pubitemid 28164472)
5. Steinle A, Groh V, Spies T. Diversification, expression, and gamma delta T cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules. Proc Natl Acad Sci U S A. 1998;95:12510-12515. (Pubitemid 28483795)
6. Qi J, Zhang J, Zhang S, Cui L, He W. Immobilized MICA could expand human Vδ1 γδ T cells in vitro that displayed major histocompatibility complex class I chain-related A-dependent cytotoxicity to human epithelial carcinomas. Scand J Immunol. 2003;58:211-220. (Pubitemid 36904314)
7. Zhao J, Huang J, Chen H, Cui L, He W. Vδ1 T cell receptor binds specifically to MHC I chain related A: molecular and biochemical evidences. Biochem Biophys Res Commun. 2005;339:232-240. (Pubitemid 41697540)
8. Spada FM, Grant EP, Peters PJ, et al. Self-recognition of CD1 by γδT cells: implications for innate immunity. J Exp Med. 2000;191:937-948. (Pubitemid 30691396)
9. Poggi A, Venturino C, Catellani S, et al. Vδ1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leaukemic B cells and up-regulated by trans-retinoic. Acid Cancer Res. 2004;4:9172-9179. (Pubitemid 39665533)
10. Catellani S, Poggi A, Bruzzone A, et al. Expansion of V{delta}1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16 binding proteins. Blood. 2007;109:2078-2085. (Pubitemid 46348208)
11. Eberl M, Jomaa HA. genetic basis for human γδ T-cell reactivity towards microbial pathogens. Trends Immunol. 2003;24:407-409. (Pubitemid 36928095)
12. Morita CT, Lee HK, Leslie DS, Tanaka Y, Bukowski JF, Marker-Herman E. Recognition of nonpeptide prenyl pyrophosphate antigens by human γδT cells. Microbes Infect. 1999;1:175-186.
13. Belmant C, Espinosa E, Halary F, el al. A chemical basis for selective recognition of nonpeptide antigens by human γδT cells. FASEB J. 2000;14: 1669-1670. (Pubitemid 30688613)
14. Pfeffer K, Schoel B, Plesnila N, et al. lectin-binding, protease-resistant mycobacterial ligand specifically activates gamma 9+ human gamma delta T cells. J Immunol. 1992;148:575-583.
15. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol. 2003;3:781-790.
16. Rincon-Orozco B, Kunzmann V, Wrobel P, Kabelitz D, Steinle A, Herrmann T. Activation of Vγ9Vδ2 T cells by NKG2D. J Immunol. 2005;175: 2144-2151.
17. Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999;285:727-729. (Pubitemid 129505074)
18. Das H, Groh V, Kuijl C, et al. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity. 2001;15:83-93. (Pubitemid 32728322)
19. Wrobel P, Shojaei H, Schittek B, et al. Lysis of a broad range of epithelial tumour cells by human γδT cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. Scand J Immunol. 2007;66:320-328. (Pubitemid 47063194)
20. Cosman D, Mullberg J, Sutherland CL, et al. ULBPs, novel MHC class I related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 2001;14:123-133. (Pubitemid 32206515)
21. Radosavljevic M, Cuillerier B, Wilson MJ, et al. A cluster of ten novel MHC class I related genes on human chromosome 6q24.2Cross D signq25.3. Genomics. 2002;79:114-123.
22. Jan Chalupny N, Sutherland CL, Lawrence WA, Rein-Weston A, Cosman D. ULBP4 is a novel ligand for human NKG2D. Biochem Biophys Res Commun. 2003;305:129-135. (Pubitemid 36535417)
23. Conejo-Garcia JR, Benencia F, Courreges MC, et al. Letal, a tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells. Cancer Biol Ther. 2003; 2:446-451.
24. Bacon L, Eagle RA, Meyer M, Easom N, Young NT, Trowsdale J. Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J Immunol. 2004;173:1078-1084. (Pubitemid 38924282)
25. Eagle RA, Traherne JA, Ashiru O, Wills MR, Trowsdale J. Regulation of NKG2D ligand gene expression. Hum Immunol. 2006;67:159-169. (Pubitemid 43673921)
26. Cao W, Xi X, Hao Z, et al. RAET1E2, a soluble isoform of the UL16 binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity. J Biol Chem. 2007;282:18922-18928. (Pubitemid 47100170)
27. Cao W, Xi X Wang Z, el al. Four novel ULBP splice variants are ligands for human NKG2D. Int Immunol. 2008;20:981-991.
28. Cao W, Hao Z, Xi X, et al. Xi bao yu fen zi mian yi xue za zhi. Chin J Cell Mol Immunol. 2007;23: 242-245.
29. International ImMunoGeneTics Information System. IMGT/V-QUEST. http://imgt.cines.fr/. Accessed December 16, 2007.
30. Xu C, Zhang H, Hu H, et al. gammadelta T cells recognize tumor cells via CDR3delta region. Mol Immunol. 2007;44:302-310. (Pubitemid 44308356)
31. Chen H, He X, Wang Z, et al. Identification for human TCRγδ-recognized epitopes/proteins via CDR3δ peptide-based immuno-biochemical strategy. J Biol Chem. 2008;283:12528-12537.
32. Chen J, Niu H, He W, Ba D. Antitumor activity of expanded human tumor-infiltrating gamma/delta T lymphocytes. Int Arch Allergy Immunol. 2001; 125:256-263. (Pubitemid 32722298)
33. Takayama H, Trenn G, Sitkovsky MV. A novel cytotoxic T lymphocyte activation assay: optimized conditions for antigen receptor triggered granule enzyme secretion. J Immunol Methods. 1987; 104:183-190. (Pubitemid 17165829)
34. Wu J, Song Y, Bakker AB, et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 1999;285:730-732. (Pubitemid 129505075)
35. Billadeau DD, Upshaw JL, Schoon RA, et al. NKG2D DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat Immunol. 2003;4:557-564.
36. André P, Castriconi R, Espeli M, et al. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors. Eur J Immunol. 2004;34:961-967. (Pubitemid 39255974)
37. Scotet E, Martinez LO, Grant E, et al. Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity. 2005; 22:71-80. (Pubitemid 40143452)
38. Thedrez A, Sabourin C, Gertner J, et al. Self/non-self discrimination by human γδT cells: simple solutions for a complex issue? Immunol Rev. 2007;215:123-135. (Pubitemid 46212235)
39. Espinosa E, Belmant C, Sicard H, Poupot R, Bonneville M, Fournie JJ. Y2K+1 state-of-the-art on non-peptide phosphoantigens, a novel category of immunostimulatory molecules. Microbes Infect. 2001;3:645-654. (Pubitemid 32607760)
40. Hou J, McKeehan K, Kan M, et al. Identification of tyrosines 154 and 307 in the extracellular domain and 653 and 766 in the intracellular domain as phosphorylation sites in the heparin-binding fibroblast growth factor receptor tyrosine kinase (flg). Protein Sci. 1993;2:86-92. (Pubitemid 23029012)
41. Zimina EP, Fritsch A, Schermer B, et al. Extracellular phosphorylation of collagen XVII by ectocasein kinase 2 inhibits ectodomain shedding. J Biol Chem. 2007;282:22737-22746. (Pubitemid 47267317)
42. Redegeld FA, Caldwell CC, Sitkovsky MV. Ectoprotein kinases: ecto-domain phosphorylation as a novel target for pharmacological manipulation? Trends Pharmacol Sci. 1999;20:453-459.